Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China

BEIJING, Dec. 23, 2021 /PRNewswire/ -- According to Yiling Pharmaceutical's notice on Thursday (UTC+8), the Depression-resolving and Restlessness-relieving Capsules have been approved for marketing

Related Keywords

Beijing ,China ,Yiling ,Jiangxi ,Chinese ,Kostenloser Wertpapierhandel ,China National Medical Products Administration ,Yiling Pharmaceutical ,Restlessness Relieving Capsules ,Drug Registration Certificate ,National Medical Products Administration ,Hamilton Depression Scale ,Hamilton Anxiety Scale ,Heart Nourishing Tranquilization ,Lianhua Qingwen Capsules ,Tongxinluo Capsules ,Shensong Yangxin Capsules ,Qiliqiangxin Capsules ,Harmaceutical ,Patent ,Depression ,Resolving ,Drug ,Approved ,Marketing ,